ICMR and Panacea Biotec announces initiation of Phase 3 clinical trial for a dengue vaccine in India

Aug 14, 2024

The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue...

RDIF, Panacea Biotec launch production of Sputnik V COVID-19 vaccine in India

May 24, 2021

Moscow [Russia], May 24 : The Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, on Monday...

Panacea Biotec to collaborate with US-based Refana Inc for COVID-19 vaccine

Jun 10, 2020

New Delhi [India], June 10 : Biotechnology major Panacea Biotec said on Wednesday it is collaborating with Refana Inc of the United States to...

50,000 people taking part in phase 3 trial of Chinese COVID-19 Vaccine

Sep 05, 2020

Beijing [China], August 05 (ANI/Sputnik): Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine...

COVID-19: RDIF collabs with Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India

Apr 07, 2021

New Delhi [India], April 7 : One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund...

Miltenyi Biotec India and BIRAC Sign Letter of Intent to Advance India's Cell and Gene Therapy Ecosystem

Jun 19, 2025

Mumbai (Maharashtra) [India], June 19: In a significant step toward strengthening India's leadership in cutting-edge biotherapeutics, Miltenyi Biotec India Private Limited and the Biotechnology...